BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15627258)

  • 1. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer.
    Porceddu SV; Jarmolowski E; Hicks RJ; Ware R; Weih L; Rischin D; Corry J; Peters LJ
    Head Neck; 2005 Mar; 27(3):175-81. PubMed ID: 15627258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
    Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET monitoring of therapy response in head and neck squamous cell carcinoma.
    Schöder H; Fury M; Lee N; Kraus D
    J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer.
    Zundel MT; Michel MA; Schultz CJ; Maheshwari M; Wong SJ; Campbell BH; Massey BL; Blumin J; Wilson JF; Wang D
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e825-32. PubMed ID: 21300450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.
    Gourin CG; Boyce BJ; Williams HT; Herdman AV; Bilodeau PA; Coleman TA
    Laryngoscope; 2009 Nov; 119(11):2150-5. PubMed ID: 19544378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
    Yao M; Smith RB; Graham MM; Hoffman HT; Tan H; Funk GF; Graham SM; Chang K; Dornfeld KJ; Menda Y; Buatti JM
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):991-9. PubMed ID: 16099601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
    Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies in surgical management of the node-positive neck after chemoradiation.
    Lango MN; Myers JN; Garden AS
    Semin Radiat Oncol; 2009 Jan; 19(1):24-8. PubMed ID: 19028342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.
    Gourin CG; Watts TL; Williams HT; Patel VS; Bilodeau PA; Coleman TA
    Laryngoscope; 2008 Apr; 118(4):671-5. PubMed ID: 18197136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
    Börjesson PK; Jauw YW; Boellaard R; de Bree R; Comans EF; Roos JC; Castelijns JA; Vosjan MJ; Kummer JA; Leemans CR; Lammertsma AA; van Dongen GA
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2133-40. PubMed ID: 16609026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy?
    Yao M; Hoffman HT; Chang K; Funk GF; Smith RB; Tan H; Clamon GH; Dornfeld K; Buatti JM
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):707-13. PubMed ID: 17379453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
    Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
    Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of PET/CT in determining need for neck dissection after primary chemoradiation for advanced head and neck squamous cell carcinoma.
    Lyford-Pike S; Ha PK; Jacene HA; Saunders JR; Tufano RP
    ORL J Otorhinolaryngol Relat Spec; 2009; 71(5):251-6. PubMed ID: 19776658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy.
    Bruzzi JF; Swisher SG; Truong MT; Munden RF; Hofstetter WL; Macapinlac HA; Correa AM; Mawlawi O; Ajani JA; Komaki RR; Fukami N; Erasmus JJ
    Cancer; 2007 Jan; 109(1):125-34. PubMed ID: 17146785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of planned neck dissection for advanced metastatic disease in tongue base or tonsil squamous cell carcinoma treated with radiotherapy.
    Roy S; Tibesar RJ; Daly K; Pambucian S; Lee HK; Gapany M; Adams GL
    Head Neck; 2002 May; 24(5):474-81. PubMed ID: 12001078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
    Basu D; Siegel BA; McDonald DJ; Nussenbaum B
    Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic work-up and outcome of cervical metastases from an unknown primary.
    Guntinas-Lichius O; Peter Klussmann J; Dinh S; Dinh M; Schmidt M; Semrau R; Mueller RP
    Acta Otolaryngol; 2006 May; 126(5):536-44. PubMed ID: 16698706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy response in head and neck cancer - evaluation of the primary tumour site.
    Sjövall J; Brun E; Almquist H; Kjellén E; Wahlberg P
    Acta Otolaryngol; 2014 Jun; 134(6):646-51. PubMed ID: 24707930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined radiotherapy with planned neck dissection for small head and neck cancers with advanced cervical metastases.
    Wang SJ; Wang MB; Yip H; Calcaterra TC
    Laryngoscope; 2000 Nov; 110(11):1794-7. PubMed ID: 11081586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.